We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$948M
AUM Growth
+$41M
Cap. Flow
+$12.7M
Cap. Flow %
1.34%
Top 10 Hldgs %
27.51%
Holding
266
New
20
Increased
64
Reduced
83
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$8.88M
2
WAB icon
Wabtec
WAB
+$4.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.26M
4
JPM icon
JPMorgan Chase
JPM
+$1.62M
5
XLRN
Acceleron Pharma
XLRN
+$1.57M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$6.45M
2
WFC icon
Wells Fargo
WFC
+$1.74M
3
HSIC icon
Henry Schein
HSIC
+$1.42M
4
UPS icon
United Parcel Service
UPS
+$1.09M
5
CB icon
Chubb
CB
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 16.99%
2 Industrials 14.77%
3 Financials 14.58%
4 Technology 13.43%
5 Energy 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWR icon
26
Quanta Services
PWR
$101B
$10.6M 1.12%
316,835
+17,976
+6% +$629K
WAB icon
27
Wabtec
WAB
$49.8B
$10.5M 1.11%
106,347
+47,865
+82% +$4.45M
WFC icon
28
Wells Fargo
WFC
$266B
$10.3M 1.09%
186,354
-32,416
-15% -$1.74M
HD icon
29
Home Depot
HD
$348B
$10.3M 1.09%
52,929
-1,068
-2% -$199K
RTX icon
30
RTX Corp
RTX
$300B
$9.74M 1.03%
123,780
+8,220
+7% +$644K
META icon
31
Meta Platforms (Facebook)
META
$1.5T
$9.63M 1.02%
49,580
+365
+0.7% +$66K
AGN
32
DELISTED
Allergan plc
AGN
$9.55M 1.01%
57,302
+55,287
+2,744% +$8.88M
CELG
33
DELISTED
Celgene Corp
CELG
$9.18M 0.97%
115,580
-9,691
-8% -$805K
UNP icon
34
Union Pacific
UNP
$176B
$8.84M 0.93%
62,408
+800
+1% +$112K
HON icon
35
Honeywell
HON
$76.4B
$8.79M 0.93%
67,594
+1,998
+3% +$266K
BXMT icon
36
Blackstone Mortgage Trust
BXMT
$2.36B
$8.63M 0.91%
274,651
+11,233
+4% +$354K
IBM icon
37
IBM
IBM
$220B
$8.63M 0.91%
64,583
-4,443
-6% -$620K
SLB icon
38
SLB Ltd
SLB
$76.8B
$8.46M 0.89%
126,162
+6,350
+5% +$436K
PG icon
39
Procter & Gamble
PG
$340B
$8.45M 0.89%
108,229
+5,686
+6% +$428K
LRCX icon
40
Lam Research
LRCX
$387B
$8.25M 0.87%
477,030
-580
-0.1% -$11.2K
J icon
41
Jacobs Solutions
J
$16.7B
$8.14M 0.86%
155,000
-1,471
-0.9% -$75.7K
FDX icon
42
FedEx
FDX
$74.8B
$8.05M 0.85%
35,474
+2,790
+9% +$691K
EMR icon
43
Emerson Electric
EMR
$87.3B
$7.93M 0.84%
114,650
-475
-0.4% -$33.4K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.13T
$7.82M 0.83%
41,905
+1,405
+3% +$274K
AXP icon
45
American Express
AXP
$232B
$7.6M 0.8%
77,580
-750
-1% -$73.7K
IBB icon
46
iShares Biotechnology ETF
IBB
$9.48B
$7.15M 0.75%
65,069
-2,035
-3% -$218K
PEP icon
47
PepsiCo
PEP
$189B
$7.09M 0.75%
65,141
+673
+1% +$69.5K
PFE icon
48
Pfizer
PFE
$148B
$7.05M 0.74%
204,894
-1,054
-0.5% -$36K
CB icon
49
Chubb
CB
$136B
$6.36M 0.67%
50,081
-6,850
-12% -$910K
GBDC icon
50
Golub Capital BDC
GBDC
$3.4B
$6.07M 0.64%
338,870
-5,510
-2% -$98.5K
1
2
3 4 5

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q2 2018 Portfolio in Review

As of Q2 2018, Neville Rodie & Shaw held 266 positions worth $948M, up 4.5% from $907M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Neville Rodie & Shaw's Q2 2018 filing shows 20 new, 64 increased, 83 reduced and 5 closed positions. Its largest new stake was Acceleron Pharma: 42,964 shares worth $2.08M. The largest sale was Invesco QQQ Trust, an estimated $6.45M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Financials.

  • Neville Rodie & Shaw's largest Q2 2018 buy was Acceleron Pharma: 42,964 shares worth $2.08M.
  • Neville Rodie & Shaw added most to Allergan plc in Q2 2018, an estimated $8.88M increase.
  • Neville Rodie & Shaw's biggest Q2 2018 reduction was Wells Fargo, cutting an estimated $1.74M.
  • Neville Rodie & Shaw fully exited Invesco QQQ Trust in Q2 2018, selling an estimated $6.45M.
  • Neville Rodie & Shaw's ten largest holdings make up 28% of its $948M portfolio in Q2 2018.
  • Neville Rodie & Shaw opened 20 new positions and closed 5 in Q2 2018.
  • Neville Rodie & Shaw's portfolio value rose 4.5% quarter-over-quarter to $948M.

Based on Neville Rodie & Shaw's 13F filing for Q2 2018, filed 3 Jul 2018.